Definitive Healthcare Corp. Files Definitive Proxy Statement

Ticker: DH · Form: DEF 14A · Filed: Apr 9, 2024 · CIK: 1861795

Definitive Healthcare Corp. DEF 14A Filing Summary
FieldDetail
CompanyDefinitive Healthcare Corp. (DH)
Form TypeDEF 14A
Filed DateApr 9, 2024
Risk Level
Pages16
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: Proxy Statement, Definitive Healthcare, SEC Filing, Shareholder Meeting, Corporate Governance

TL;DR

<b>Definitive Healthcare Corp. has filed its Definitive Proxy Statement for the fiscal year ending December 31, 2023.</b>

AI Summary

Definitive Healthcare Corp. (DH) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Definitive Healthcare Corp. filed a Definitive Proxy Statement on April 9, 2024. The filing pertains to the fiscal year ending December 31, 2023. The company's principal executive offices are located in Framingham, MA. The filing is made under the Securities Exchange Act of 1934. No fee was required for this filing, as indicated by the company.

Why It Matters

For investors and stakeholders tracking Definitive Healthcare Corp., this filing contains several important signals. This filing is a standard requirement for publicly traded companies to provide shareholders with information regarding upcoming meetings and voting matters. Shareholders will use this document to make informed decisions on corporate governance and executive compensation.

Risk Assessment

Risk Level: — Definitive Healthcare Corp. shows moderate risk based on this filing. The filing is a routine proxy statement, indicating no immediate material changes or significant events requiring a higher risk assessment.

Analyst Insight

Review the proxy statement for details on shareholder proposals, director nominations, and executive compensation to understand potential impacts on corporate governance.

Key Numbers

  • 2024-04-09 — Filing Date (Date of filing)
  • 2023-12-31 — Fiscal Year End (Period of report)

Key Players & Entities

  • Definitive Healthcare Corp. (company) — Registrant
  • Securities Exchange Act of 1934 (regulator) — Act under which filing is made
  • Framingham, MA (location) — Business Address

FAQ

When did Definitive Healthcare Corp. file this DEF 14A?

Definitive Healthcare Corp. filed this Proxy Statement (DEF 14A) with the SEC on April 9, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Definitive Healthcare Corp. (DH).

Where can I read the original DEF 14A filing from Definitive Healthcare Corp.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Definitive Healthcare Corp..

What are the key takeaways from Definitive Healthcare Corp.'s DEF 14A?

Definitive Healthcare Corp. filed this DEF 14A on April 9, 2024. Key takeaways: Definitive Healthcare Corp. filed a Definitive Proxy Statement on April 9, 2024.. The filing pertains to the fiscal year ending December 31, 2023.. The company's principal executive offices are located in Framingham, MA..

Is Definitive Healthcare Corp. a risky investment based on this filing?

Based on this DEF 14A, Definitive Healthcare Corp. presents a moderate-risk profile. The filing is a routine proxy statement, indicating no immediate material changes or significant events requiring a higher risk assessment.

What should investors do after reading Definitive Healthcare Corp.'s DEF 14A?

Review the proxy statement for details on shareholder proposals, director nominations, and executive compensation to understand potential impacts on corporate governance. The overall sentiment from this filing is neutral.

How does Definitive Healthcare Corp. compare to its industry peers?

Definitive Healthcare Corp. operates in the healthcare technology sector, providing data and analytics solutions.

Are there regulatory concerns for Definitive Healthcare Corp.?

The filing is made in accordance with the Securities Exchange Act of 1934, requiring public companies to disclose information to shareholders.

Industry Context

Definitive Healthcare Corp. operates in the healthcare technology sector, providing data and analytics solutions.

Regulatory Implications

The filing is made in accordance with the Securities Exchange Act of 1934, requiring public companies to disclose information to shareholders.

What Investors Should Do

  1. Review executive compensation details within the proxy statement.
  2. Analyze any shareholder proposals for potential impact on company strategy.
  3. Note the director nominations and qualifications presented.

Key Dates

  • 2024-04-09: Filing Date — Definitive Proxy Statement filed

Year-Over-Year Comparison

This is the initial filing of the Definitive Proxy Statement for the 2023 fiscal year.

Filing Stats: 4,814 words · 19 min read · ~16 pages · Grade level 12.4 · Accepted 2024-04-09 16:06:11

Filing Documents

EXECUTIVE COMPENSATION TABLES

EXECUTIVE COMPENSATION TABLES 38 Summary Compensation Table 38 Grant of Plan-Based Awards Table 39 Narrative Discussion of the Summary Compensation Table and Grants of Plan-Based Awards Table 40 Employment Agreements 40 Equity Compensation 42 Outstanding Equity Awards at Fiscal Year-End 42 Option Exercises and Stock Vested During Fiscal 2023 44 Potential Payments Upon Termination or Change-In-Control 45 Pension Benefits 52 Nonqualified Deferred Compensation 52 Pay-Versus-Performance Table 54 COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION 59 EQUITY COMPENSATION PLAN INFORMATION 59 DIRECTOR COMPENSATION 60 Non-Employee Director Compensation Policy 61 Director Stock Ownership Guidelines 62

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 63 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 67 Definitive OpCo Amended LLC Agreement 67 Tax Receivable Agreement 69 Nominating Agreements 70 Registration Rights Agreement 70 Limitation of Directors' Liability and Indemnification Matters 70 Related Party Transactions Policies and Procedures 70 HOUSEHOLDING OF PROXY MATERIALS 72 STOCKHOLDER PROPOSALS FOR THE 2025 ANNUAL MEETING 73 OTHER BUSINESS 74 APPENDIX A – RECONCILIATION OF NON-GAAP FINANCIAL MEASURES A-1 Table of Contents Definitive Healthcare Corp. 492 Old Connecticut Path, Suite 401 Framingham, MA 01701 Telephone: (508) 720-4224 PROXY STATEMENT Annual Meeting of Stockholders May 22, 2024 GENERAL INFORMATION Why am I being provided with these materials? Pursuant to rules adopted by the Securities and Exchange Commission (the "SEC"), we have elected to provide access to our proxy materials over the internet. Accordingly, the Notice of Internet Availability of Proxy Materials was mailed, and this Proxy Statement, annual report, and the form of proxy were first sent or made available to stockholders on or about April 9, 2024. We have provided these proxy materials to you in connection with the solicitation by the Board of Directors (the "Board" or "Board of Directors") of Definitive Healthcare Corp. ("we," "our," "us" and the "Company") of proxies to be voted at our Annual Meeting of Stockholders to be held on May 22, 2024 (the "Annual Meeting"), and at any postponements or adjournments of the Annual Meeting. You are invited to attend the Annual Meeting and vote your shares or to vote your shares in advance by proxy via the Internet, by telephone, or by mail. What am I voting on? There are three proposals scheduled to be voted on at the Annual Meeting: Proposal No. 1: To elect the three Class III directors of Definitive Healthcare Corp. named in this Proxy Statement,

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.